Secured NIH NIGMS SBIR Phase I Grant

🚨 Major announcement 🚨

 

Sindri Materials Corp. has officially received our first SBIR Phase I grant from the National Institute of General Medical Sciences (NIGMS)! This grant provides critical non-dilutive funding to accelerate the development and commercialization of our ultra-high-quality graphene grids, specifically designed for cryogenic electron microscopy (cryo-EM).

Winning a small business innovation research (SBIR) grant is highly competitive. For Sindri, it’s the culmination of years spent refining our technology, building our team, and learning how to clearly communicate the value and potential of our solution. This journey reinforced a crucial lesson: great science must be matched by clear articulation of the problem you're solving and why your solution matters.

For the cryo-EM community, we know firsthand the frustrations inherent in grid preparation that often are contaminated, broken, and slow down critical research. Sindri's clean, continuous graphene membranes directly address these challenges, enabling researchers to capture clearer, higher-resolution structures faster and more reliably.

We're deeply grateful to NIGMS, our program officers, and reviewers whose feedback strengthened our proposal and sharpened our message. Above all, thank you to the Sindri team for your persistence, skill, and relentless focus.

This grant comes at a transformative moment for us. With our team rapidly growing and significant market momentum, we're now positioned to deliver meaningful impact; equipping researchers with tools to accelerate discoveries that shape global health.

We’re just getting started...